Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
0.5390
-0.0322 (-5.64%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Biodesix Market Cap
Biodesix has a market cap or net worth of $78.68 million as of April 28, 2025. Its market cap has decreased by -43.70% in one year.
Market Cap
78.68M
Enterprise Value
115.82M
1-Year Change
-43.70%
Ranking
Category
Stock Price
$0.54
Market Cap Chart
Since October 28, 2020, Biodesix's market cap has decreased from $336.31M to $78.68M, a decrease of -76.60%. That is a compound annual growth rate of -27.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 78.68M | -64.65% |
| Dec 31, 2024 | 222.56M | 33.69% |
| Dec 29, 2023 | 166.48M | -5.38% |
| Dec 30, 2022 | 175.94M | 23.06% |
| Dec 31, 2021 | 142.97M | -73.28% |
| Dec 31, 2020 | 535.07M | 59.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 785.30B |
| UnitedHealth Group | 379.56B |
| Johnson & Johnson | 369.48B |
| AbbVie | 328.38B |
| Novo Nordisk | 276.96B |
| Abbott Laboratories | 222.98B |
| AstraZeneca | 215.41B |
| Novartis AG | 211.71B |